ESMO Asia 2022 | Latest developments in immunotherapy for advanced/recurrent endometrial cancer

Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, talks on the latest clinical trial results, discussed at ESMO Asia 2022, investigating immunotherapy for patients with advanced or recurrent endometrial cancer. Dr Lorusso also discusses the possible impact of these findings on clinical practice. This interview took place at the European Society for Medical Oncology (ESMO) Asia congress 2022 in Singapore.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.